Glow Blend 70mg (GHK-CU 50mg, BPC-157 10mg, TB-500 10mg)

Glow Blend 70mg — Overview

The Glow Blend is a three-peptide research formulation that combines GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg in one vial. It’s similar to its four-component sibling, the Klow Blend 80mg, as both are designed for researchers investigating tissue repair and regeneration across overlapping biological pathways. However, this blend lacks the melanocortin-receptor component found in KPV. That makes it a more targeted choice for labs focusing specifically on structural tissue repair, angiogenesis, and extracellular matrix remodelling. This product is for research purposes only and is not intended for human administration; it should only be handled by qualified investigators.

Component Breakdown

GHK-Cu 50mg

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) stands out as one of the most thoroughly researched bioactive tripeptides in repair biology. It’s naturally found in human plasma, saliva, and urine, but those levels drop off significantly as we age. This sharp decline is exactly why researchers are so interested in whether supplementing it in lab models can help restore certain regenerative processes.

It works primarily by stimulating collagen and glycosaminoglycan synthesis while promoting fibroblast migration and proliferation. It also activates a wide range of tissue repair genes by modulating the ubiquitin–proteasome pathway and TGF-β signalling. It’s got antioxidant properties too, likely mediated through copper-catalysed superoxide dismutase activity. GHK-Cu’s range of effects is quite unusual, making it a major focus in skin biology, wound healing, and anti-ageing research. For isolated studies, the GHK-Cu 50mg vial is available separately.

BPC-157 10mg

BPC-157 (Body Protection Compound 157) is a 15-amino-acid peptide that’s drawn a massive amount of preclinical interest since it was first characterised in the 1990s. Its effects aren’t limited to one area, either. In the gastrointestinal tract, it helps maintain mucosal integrity and speeds up healing, while in musculoskeletal tissue, it’s been shown to accelerate recovery from tendon, ligament, and muscle injuries. Systemically, the peptide modulates nitric oxide production and promotes angiogenesis, which is really what drives most of its repair-related properties.

What makes BPC-157 stand out as a research tool is its remarkable stability under acidic conditions. Because it doesn’t degrade easily in gastric environments, researchers can effectively compare different administration routes in animal models. If your study requires single-compound protocols, we also provide BPC-157 5mg and the BPC-157 5mg / TB-500 5mg Blend.

TB-500 10mg

Thymosin Beta-4 (TB-500) is a synthetic version of a natural actin-binding protein found in almost every tissue type. It’s well-known for its role in tissue repair, where it helps cells move by balancing G-actin and F-actin. It also boosts angiogenic factors and cuts down inflammation by lowering inflammatory cytokines. While research is still ongoing, some cardiac and neurological injury models show signs of cytoprotective and regenerative signalling. If you’re focusing on this peptide alone, you can find it in the Thymosin Beta-4 (TB-500) 5mg vial. This product is for research purposes only and is not intended for human administration; it should only be handled by qualified investigators.

Why Study These Three Together?

By combining GHK-Cu, BPC-157, and TB-500, this blend taps into several distinct yet synergistic repair mechanisms. GHK-Cu handles copper-mediated gene activation and collagen synthesis, while BPC-157 drives angiogenesis via nitric oxide and offers multi-tissue cytoprotection. TB-500 rounds things out by managing actin dynamics for cell migration and anti-inflammatory signalling. While all three pathways are vital for wound healing and tissue repair, they work through different receptors and molecular intermediates.

If you’re designing experiments to model accelerated repair or exploring how different biological repair mechanisms interact, this blend offers a biologically coherent combination. It also cuts down on the practical headache of managing three separate reconstitution and storage protocols at once—a real factor to consider in a busy research environment.

If researchers are seeking a complementary anti-inflammatory element for a model, they could add KPV 5mg to the Glow Blend or simply upgrade to the Klow Blend, which already includes KPV as its fourth component.

Format & Quality

This vial holds a total of 70mg, consisting of GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg in a lyophilised powder form. We ensure purity and identity are independently third-party verified for every batch. Certificates of analysis are available to research teams upon request.

Intended Use

Glow Blend 70mg is supplied for research purposes only. It’s intended for in vitro, ex vivo, or preclinical research by qualified investigators and isn’t approved or intended for use in humans. It is not intended for human administration or diagnostic use.

References

• • Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.” Int J Mol Sci. 2018;19(7):1987.
  • Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” J Appl Physiol. 2011;110(3):774–780.
  • Smart N, et al. “De novo cardiomyocytes from within the activated adult heart after injury.” Nature. 2011;474(7353):640–644. (Thymosin β4 cardiac context)
  • Sikiric P, et al. “Brain-gut axis and pentadecapeptide BPC 157.” Curr Neuropharmacol. 2016;14(8):857–865.